Year: 2023
Reference No.: IB No. 2023-031
Category: Notice to Proceed
Approved Budget for the Contract: 548,430,000.00
Awardee/Supplier: Faberco Life Sciences Inc. and Serum Institute of India Pvt. Ltd. – Joint Venture
Date of NOA: Thursday, March 9, 2023
PO/Contract No.: GOP-C-2023-036
Effectivity and Expiration Date of Contract: Tuesday, April 4, 2023 to Wednesday, August 2, 2023
NTP Contract Date: Monday, April 3, 2023
Contract Period: 1st Tranche = 1,500,000 doses for 90 cd upon receipt of approved NTP and 2nd Tranche = 1,530,000 doses for 120 cd upon receipt of approved NTP
Name of Winning Bidder: Faberco Life Sciences Inc. and Serum Institute of India Pvt. Ltd. – Joint Venture
Official Business Address: 2nd and 3rd Floor One Armstrong Building, Armstrong Avenue corner Yosimete St. Moonwalk Subdivision, Phase I, Paranaque City
Amount of Contract Awarded: 381,780,000.00
Date of Award: Thursday, March 9, 2023
Date of Acceptance: Friday, March 10, 2023
Implementing Office/End-User Unit/s: Disease Prevention and Control Bureau
Date Posted: April 05, 2023